ASCO 2025: Adding nivolumab to chemoradiotherapy after surgery can decrease chance of recurrence in head and neck cancer
Results from the international phase 3 NIVOPOSTOP clinical trial found that adding nivolumab to chemoradiotherapy…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
ASCO 2025: Pro-inflammatory diets associated with worse outcomes for stage III colon cancer
Results from a large, prospective cohort study show that eating a less inflammatory diet may…
ASCO 2025: Avelumab cetuximab combo improves PFS for for cutaneous squamous cell carcinoma
In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC),…
ASCO 2025: First phase 2 RCT of CAR T-cell therapy in solid tumours finds promising results
Patients with advanced gastric or gastro-oesophageal junction (GEJ) cancer treated with CAR T-cell therapy lived…
ASCO 2025: Artificial intelligence assistance can help improve accuracy in identifying HER2-low and HER2-ultralow breast cancers, avoid misclassification
Results from a multinational study found that using artificial intelligence (AI) assistance can help pathologists…
ASCO 2025: GLP-1 receptor agonists may slightly reduce risk of fourteen obesity-related cancers for people with diabetes
A large observational study of more than 170,000 patients with diabetes and obesity in the…
ASCO 2025: Trastuzumab deruxtecan can help some people with advanced gastric cancers live about 3 months longer
The international phase 3 DESTINY-Gastric04 clinical trial found that second-line treatment with trastuzumab deruxtecan can help…
ASCO 2025: Experimental Drug Development Centre announces the presentation of updated data from the phase 1 study of antibody-drug conjugate EBC-129
The Ental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development, has…
ASCO 2025 Special Part 1! S3E4 The Oncology Journal Club
Welcome to Part 1 of the 2025 ASCO ASM Special of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson to unpack practice changing presentations from Chicago.
Global warming may raise women’s cancer risk
Scientists investigating the impact of climate change on women’s health have found that increased heat…